A0A0S2Z4Z8 (A0A0S2Z4Z8_HUMAN) Homo sapiens (Human)
Receptor-interacting serine-threonine kinase 2 isoform 1 UniProtKBInterProInteractive Modelling
540 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: O43353
Available Structures
33 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of RIP2K dimer bound to the XIAP BIR2 domain |
Heteromer O43353; P98170; | 100.0 | 1×ZN; | |||
| p75NTR DD:RIP2 CARD |
Heteromer O43353; P08138; | 100 | ||||
| Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide |
Heteromer O43353; P31947; | 100 | 2×CA; 6×MG; | |||
| Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide and stabilizer Fusicoccin-A |
Heteromer O43353; P31947; | 100 | 2×FSC; 4×MG; 2×CL; | |||
| Structure of RIP2 CARD domain | homo-12-mer | 100 | ||||
| Structure of RIP2 CARD filament | homo-10-mer | 100 | ||||
| Structure of RIP2 CARD domain fused to crystallisable MBP tag | homo-4-mer | 100 | 4×GLC; | |||
| Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3 | homo-2-mer | 100.0 | 2×KRE; | |||
| Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18 | homo-2-mer | 100.0 | 2×E7N; | |||
| RIPK2 in complex with K252 | homo-2-mer | 100.0 | 2×6IL; | |||
| The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-in… | homo-2-mer | 100.0 | 2×6GE; 5×SO4; | |||
| Structure of the kinase domain of human RIPK2 in complex with ponatinib | homo-2-mer | 100.0 | 2×0LI; 1×EDO; | |||
| RIP2K kinase domain dimer with bound compound 37 (N399), a speific NOD1 pathway inhibitor | homo-2-mer | 100.0 | 2×A1H90; | |||
| RIP2 Kinase Catalytic Domain (1 - 310) | homo-2-mer | 100.0 | 1×CA; | |||
| The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-in… | homo-2-mer | 100.0 | 2×6GD; | |||
| RIP2 Kinase Catalytic Domain complex with 2({4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)… | homo-2-mer | 100.0 | 2×KA2; | |||
| RIP2 Kinase Catalytic Domain (1 - 310) complex with Benzimidazole | homo-2-mer | 100.0 | 1×CA; 2×IQ7; | |||
| RIP2 Kinase Catalytic Domain complex with N(4,5dimethyl1Hpyrazol3yl)7methoxy6(2methylpropane2sulfon… | homo-2-mer | 100.0 | 2×GEZ; | |||
| RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide. | homo-2-mer | 100.0 | 2×M5W; 1×CA; | |||
| RIP2 Kinase Catalytic Domain complex with 2(4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)q… | homo-2-mer | 100.0 | 2×K9T; 1×CA; | |||
| RIP2 Kinase Catalytic Domain (1 - 310) complex with SB-203580 | homo-2-mer | 100.0 | 2×SB2; | |||
| Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases. | homo-2-mer | 100.0 | 2×9XA; | |||
| RIP2 Kinase Catalytic Domain complex with 5-Amino-1-Phenylpyrazole-4-Carboxamide. | homo-2-mer | 100.0 | 2×M2B; 1×CA; | |||
| RIP2 Kinase Catalytic Domain (1 - 310) complex with Biaryl Urea | homo-2-mer | 100.0 | 2×SR8; | |||
| RIP2 Kinase Catalytic Domain (1 - 310) complex with AMP-PCP | homo-2-mer | 100.0 | 2×ACP; 2×MG; | |||
| RIP2 Kinase Catalytic Domain (1 - 310) complex with Biphenylsulfonamide | homo-2-mer | 100.0 | 2×XYW; | |||
| Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases | homo-2-mer | 100.0 | 2×9WS; 3×SO4; | |||
| Structure of RIP2K(L294F) with bound AMPPCP | homo-2-mer | 99.64 | 2×ACP; 2×MG; 1×CO; | |||
| Structure of RIP2K(D146N) with bound Staurosporine | homo-2-mer | 99.64 | 2×STU; 6×PO4; | |||
| Crystal structure of the kinase domain of human RIPK2 in complex with the activation loop targeting… | monomer | 100.0 | 1×BW8; | |||
| RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9… | monomer | 99.28 | 1×Q9J; | |||
| Structure of inactive kinase RIP2K(K47R) | monomer | 99.64 | 6×SO4; | |||
| Solution structure of RIP2 CARD | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8x2o.1.A | homo-2-mer | 0.79 | 2×6IL; | 100.00 | ||